
Primary Clinic (Direct GLP) Review
Best for: GLP-1 at wholesale cost inside a Direct Primary Care membership
Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace. For $89/mo members get unlimited primary care, direct text access, same-day virtual visits and routine labs — then buy compounded 503A GLP-1s at wholesale with no markup: semaglutide from $65/mo, tirzepatide from $110/mo. Currently available in 10 states, with medication monitoring built into an ongoing care relationship.
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Primary Clinic (Direct GLP) is one of the most affordable GLP-1 options on the market.
Primary Clinic (Direct GLP) at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $65/mo
- Pricing model
- Scales with dose — higher doses cost more
- Availability
- 10 states
- FDA status
- No FDA warning letter on record
How we scored Primary Clinic (Direct GLP)
Each dimension is scored algorithmically from Primary Clinic (Direct GLP)’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.1/10At $65/mo, Primary Clinic (Direct GLP) runs about 62% below the $170 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.3/10Primary Clinic (Direct GLP) offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience; 4 platform features disclosed.
Trust & Safety15%
8.7/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
6.7/10Primary Clinic (Direct GLP) is available in 10 states — confirm yours is covered.
Support10%
6.1/10Primary Clinic (Direct GLP) provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Primary Clinic (Direct GLP) review
Last checked 2026-06-06- Confirmed current pricing across 8 dose/plan tiers
- Confirmed availability in 10 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Primary Clinic (Direct GLP) offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Primary Clinic (Direct GLP)'s current pricing and active discounts before you decide.
What we like
- Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
- GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
- Routine labs and thousands of medications included in membership — no surprise bills
- Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide
- Publishes the FDA 503A compounded-medication disclaimer
Watch-outs
- 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
- Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
- 503A pharmacy partners not named
- LegitScript certification not mentioned on the site
- Medical director and corporate legal entity not disclosed
- Compounded only — no brand-name Wegovy, Ozempic, Mounjaro, or Zepbound
- Refund policy not disclosed publicly
A doctor's office that happens to sell GLP-1s, not a GLP-1 store with a doctor attached
Primary Clinic (it runs on the domain directglp1.com, which is where the "Direct GLP" alt-name comes from) is built differently from almost every other name in this directory. Most platforms here are direct-to-consumer storefronts: you pay a bundled monthly fee, a medication shows up, and the clinical relationship is thin. Primary Clinic is a Direct Primary Care (DPC) membership first. You join for a flat monthly fee that buys unlimited primary care, then you buy compounded semaglutide or tirzepatide separately at the clinic's actual wholesale cost with no markup. If you want a real ongoing care relationship wrapped around your GLP-1 — and you live in one of its ten states — it's one of the more genuinely interesting setups we've reviewed. If you just want the cheapest no-strings vial mailed to your door, the math works against you.
How the two-part price actually works
This is the part most people get wrong, so read it carefully: there are two bills, not one. The first is the membership — a flat fee in the high eighties per month that covers unlimited primary care, direct text access to a provider, same-day virtual visits, routine labs, and what the clinic describes as thousands of medications, with no co-pays or deductibles. The second is the medication itself, billed separately at wholesale. Compounded semaglutide starts at $65 a month for the lowest doses and rises with the dose; tirzepatide starts in the low three figures and climbs as you titrate up. Both drugs publish every dose tier openly — eight tiers in total — so you can see exactly what month four or month six will cost before you ever sign up.
The honest way to judge this is on the all-in number. Add the membership to a low-dose vial and you're paying noticeably more than the category median of $170 for the drug alone. But you're not buying the drug alone — you're buying primary care, labs, and provider access on top of it. Against a typical telehealth bundle, and certainly against paying over a thousand dollars a month for brand-name GLP-1s elsewhere, the package can come out ahead for the right person. For someone who only wants a vial and nothing else, the membership is pure overhead — roughly a thousand dollars a year of fixed cost you don't need.
Wholesale pricing with no markup — the real differentiator
The thing that genuinely sets Primary Clinic apart is the pricing philosophy. It doesn't treat the GLP-1 as a profit center. The medication is passed through at the clinic's wholesale cost, explicitly "with no hidden markups," because the business model is the membership, not the molecule. That's the opposite of the standard playbook, where the drug carries the margin. It means your per-dose price is unusually transparent and unusually low for the drug itself, and it means the clinic has no incentive to push you toward a pricier dose or formulation. For patients who've felt nickel-and-dimed by other platforms — surprise consult fees, dose-based upcharges, opaque "bundles" — this is a refreshing structure.
The medications and how they're dispensed
Primary Clinic offers compounded semaglutide and compounded tirzepatide, both made by licensed 503A pharmacies. There is no brand-name option here — no Wegovy, Ozempic, Mounjaro, or Zepbound — and no oral formulation; this is injectable compounded medication only. To its credit, the clinic publishes the standard FDA 503A disclaimers plainly: these compounded products are not FDA-approved brand-name medications and are "not affiliated with or approved as generic versions of brand-name GLP-1 medications," even though they contain the same active ingredients. That kind of upfront labeling is what we want to see from any compounding-based provider, and it's a point in the clinic's favor on the trust side.
Where the transparency stops
For a provider that's this open about price, a few important things stay hidden, and we won't pretend otherwise. The specific 503A pharmacy partners are never named — you're told the medication comes from licensed compounders, but not which ones, which makes it harder to vet sourcing independently. There's no LegitScript certification mentioned on the site, no named medical director, and no disclosed corporate legal entity. The refund policy isn't published either. None of these are red flags on their own — the per-dose pricing, the ten-state list, and the 503A language are all directly verifiable, which is why our verification confidence here is high — but they're real gaps, and they're the reason this isn't a slam-dunk on oversight transparency.
Availability: ten states only
This is a meaningful limit. Primary Clinic currently serves only Washington, New Mexico, Arizona, Utah, Florida, DC, Kansas, Oklahoma, Virginia, and Georgia, with more promised. The DPC model — with continuous, hands-on primary care — is harder to scale across all fifty states than a pure mail-order operation, so the narrow footprint is partly a consequence of the model itself. If you're outside those ten states, this provider simply isn't an option yet, and a 50-state platform will serve you instead.
Who should choose it — and who should skip it
- Choose it if: you live in one of the ten states, you want your GLP-1 managed inside a real, ongoing primary-care relationship with labs and direct provider access, and you value transparent wholesale drug pricing over the absolute lowest sticker number.
- Choose it if: you're already paying for fragmented care elsewhere and would happily consolidate primary care, labs, and weight management under one flat membership.
- Skip it if: you only want a compounded vial with no membership commitment — the flat monthly fee makes the all-in cost higher than drug-only competitors.
- Skip it if: you need brand-name Wegovy, Ozempic, Mounjaro, or Zepbound, an oral option, or you want a named pharmacy and published medical director before you'll trust a provider.
- Skip it if: you live outside its ten-state service area.
The bottom line
Primary Clinic is one of the few providers in our directory where the GLP-1 is the side dish, not the main course. The Direct Primary Care membership plus no-markup wholesale medication is a genuinely patient-friendly structure, and the published per-dose pricing and clear 503A disclaimers earn it real trust. The catches are the ten-state footprint, the unavoidable membership overhead if you only want the drug, and the undisclosed pharmacy partner, medical director, and corporate entity. For the patient who actually wants continuous care wrapped around their weight-loss medication — and lives in the right state — it's a strong, honest choice. For the bargain-hunter who just wants the cheapest vial, look elsewhere and compare the all-in cost using our scoring methodology.
For a side-by-side, Telos Rx ($49/month) and bmiMD ($99/month) are the most comparable options to weigh against Primary Clinic (Direct GLP).
Ready to start with Primary Clinic (Direct GLP)?
Starting at $65/month. See current pricing and start your free consultation.
Alternatives to Primary Clinic (Direct GLP)
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Primary Clinic (Direct GLP) review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Primary Clinic (Direct GLP)?
Starting at $65/month. See current pricing and start your free consultation.